|4.||Virus Diseases (Viral Diseases)
|5.||Typhoid Fever (Typhoid)
|1.||Kostyanev, Tomislav S: 1 article (01/2012)|
|2.||Sechanova, Lena P: 1 article (01/2012)|
|3.||Sayers, Jon R: 1 article (04/2002)|
|4.||Vitovski, Srdjan: 1 article (04/2002)|
|5.||Howard, Anthony J: 1 article (04/2002)|
|6.||Dunkin, Kim T: 1 article (04/2002)|
10/01/1983 - "Serum antibody against polyribosylribitol phosphate, the capsular antigen of Haemophilus influenzae type b, confers protection against experimental Haemophilus infection. "
09/01/1997 - "Thus, D15 is a highly conserved antigen that is protective in animal models and it may be a useful component of a universal subunit vaccine against Haemophilus infection and disease."
11/01/1989 - "Among the patients with invasive Haemophilus infections, 93% had antigen detected. "
|2.||Chloramphenicol (Chloromycetin)FDA Link
12/23/1950 - "[Chloramphenicol therapy of acute and chronic hemophilus infections of the bronchial mucosa]."
10/01/1987 - "Chloramphenicol is used primarily for anaerobic infections, Haemophilus influenzae meningitis, and typhoid fever. "
02/01/1983 - "Chloramphenicol is used primarily for anaerobic infections, Haemophilus influenzae meningitis, and infections due to Salmonella typhi. "
10/01/1977 - "Chloramphenicol is used primarily for anaerobic infections, Haemophilus influenzae meningitis, and infections due to Salmonella typhi. "
05/10/1989 - "Initially, benzylpenicillin and chloramphenicol are recommended, to cover haemophilus infection as well. "
|3.||Ampicillin (Omnipen)FDA LinkGeneric
05/01/1989 - "In 108 (95%) of these infections Haemophilus influenzae was isolated from the pretreatment cultures of the conjunctivae; 61 were susceptible and 47 (44%) were resistant to ampicillin by a disc diffusion technique. "
02/01/1981 - "This increase on a community hospital level parallels the increase in ampicillin resistance in Haemophilus noted in university hospitals and underscores the need for chloramphenicol (alone or in combination with ampicillin) as initial treatment for systemic Haemophilus infections."
03/21/1981 - "Cefotaxime for chloramphenicol/ampicillin resistant haemophilus infections."
|4.||Rifampin (Rifampicin)FDA LinkGeneric
|5.||Penicillins (Penicillin)FDA Link
07/01/1974 - "The significance of this remarkable osmotic stability of haemophilus L forms is discussed in relation both to testing of sensitivity of this organism to penicillins and to persistence of chronic haemophilus infections of the lower respiratory tract."
08/04/1973 - "Penicillins for Haemophilus infections."
|6.||Immunoglobulin G (IgG)IBA
|7.||Immunoglobulin A (IgA)IBA
04/03/2002 - "To compare IgA1 protease activity in nontypeable H influenzae strains isolated from patients with symptomatic Haemophilus infection (sputum, cerebrospinal fluid, blood, or normally sterile tissue) vs strains from throat swabs of asymptomatic carriers and to compare iga gene carriage and variability in nontypeable H influenzae strains. "
11/21/1977 - "[Level of IgG, IgA and IgM in Haemophilus infections in patients undergoing tonsillectomy]."
|8.||Anti-Bacterial Agents (Antibiotics)IBA
03/01/1987 - ""Breakthrough" meningitis during cefamandole therapy has documented the need for adequate cerebrospinal fluid penetration by these antibiotics if they are to be used in the therapy of Hemophilus infections. "
01/01/2012 - "Resistance to other antibiotics such as macrolides, tetracyclines, chloramphenicol, trimethoprim/sulfamethoxazole, and fluoroquinolones, commonly used to treat Haemophilus infections has also been described."
|10.||Myelin P2 ProteinIBA